Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2025-02-21 Sale | 2025-02-24 8:20 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 927 | $39.15 | $36,292 | 18,103 (Direct) | View |
2025-02-04 Sale | 2025-02-05 4:37 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 9,477 | $39.7 | $376,237 | 14,399 (Direct) | View |
2025-01-27 Sale | 2025-01-29 5:04 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 3,273 | $39.62 | $129,676 | 31,453 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2025-04-02 Other | 2025-04-03 4:27 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 16,850 | $0 | 2,047,983 (Direct) | View |
2025-03-10 Exercise | 2025-03-11 4:17 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 35,000 | $0 | 2,014,283 (Direct) | View |
2025-03-10 Tax Withholding | 2025-03-11 4:17 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 16,805 | $32.06 | 2,014,283 (Direct) | View |
2025-03-10 Exercise | 2025-03-11 4:15 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 3,800 | $0 | 12,681 (Direct) | View |
2025-03-10 Tax Withholding | 2025-03-11 4:15 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 2,017 | $32.06 | 12,681 (Direct) | View |
2025-03-07 Exercise | 2025-03-07 4:40 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 38,640 | $0 | 1,996,088 (Direct) | View |
2025-03-07 Tax Withholding | 2025-03-07 4:40 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 18,581 | $39.11 | 1,996,088 (Direct) | View |
2025-03-07 Exercise | 2025-03-07 4:34 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 2,625 | $0 | 15,151 (Direct) | View |
2025-03-07 Tax Withholding | 2025-03-07 4:34 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 1,356 | $39.11 | 15,151 (Direct) | View |
2025-03-05 Tax Withholding | 2025-03-05 4:23 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 3,193 | $33.05 | 10,898 (Direct) | View |
2025-03-05 Tax Withholding | 2025-03-05 4:21 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 910 | $33.05 | 12,704 (Direct) | View |
2025-03-05 Tax Withholding | 2025-03-05 4:19 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 1,892 | $33.05 | 13,882 (Direct) | View |
2025-03-05 Tax Withholding | 2025-03-05 4:14 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 891 | $33.05 | 9,635 (Direct) | View |
2025-02-28 Option Award | 2025-03-04 4:21 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 35,000 | $0 | 2,011,029 (Direct) | View |
2025-02-28 Option Award | 2025-03-04 4:20 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 3,800 | $0 | 17,891 (Direct) | View |
2025-02-26 Exercise | 2025-02-26 5:56 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 5,760 | $0 | 15,774 (Direct) | View |
2025-02-26 Tax Withholding | 2025-02-26 5:56 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 2,885 | $39.48 | 15,774 (Direct) | View |
2025-02-21 Tax Withholding | 2025-02-24 8:22 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 860 | $39.15 | 21,189 (Direct) | View |
2025-02-21 Exercise | 2025-02-24 8:22 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 1,650 | $0 | 21,189 (Direct) | View |
2025-02-22 Disposition | 2025-02-24 8:22 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 3,250 | $0 | 21,189 (Direct) | View |
2025-02-22 Option Award | 2025-02-24 8:22 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 3,250 | $0 | 21,189 (Direct) | View |
2025-02-21 Exercise | 2025-02-24 8:20 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 1,875 | $0 | 18,103 (Direct) | View |
2025-02-22 Disposition | 2025-02-24 8:20 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 3,250 | $0 | 18,103 (Direct) | View |
2025-02-22 Option Award | 2025-02-24 8:20 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 3,250 | $0 | 18,103 (Direct) | View |
2025-02-21 Tax Withholding | 2025-02-24 8:18 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 552 | $39.15 | 21,149 (Direct) | View |
2025-02-21 Exercise | 2025-02-24 8:18 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 1,125 | $0 | 21,149 (Direct) | View |
2025-02-22 Disposition | 2025-02-24 8:18 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 3,875 | $0 | 21,149 (Direct) | View |
2025-02-22 Option Award | 2025-02-24 8:18 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 3,875 | $0 | 21,149 (Direct) | View |
2025-02-22 Disposition | 2025-02-24 8:16 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 6,000 | $0 | 28,591 (Direct) | View |
2025-02-22 Option Award | 2025-02-24 8:16 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 6,000 | $0 | 28,591 (Direct) | View |
2025-02-22 Disposition | 2025-02-24 5:50 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director | 5,369 | $0 | 53,764 (Direct) | View |
2025-02-22 Option Award | 2025-02-24 5:50 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director | 5,369 | $0 | 53,764 (Direct) | View |
2025-02-22 Disposition | 2025-02-24 5:47 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 5,369 | $0 | 135,644 (Direct) | View |
2025-02-22 Option Award | 2025-02-24 5:47 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 5,369 | $0 | 135,644 (Direct) | View |
2025-02-22 Disposition | 2025-02-24 5:45 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 5,369 | $0 | 18,684 (Direct) | View |
2025-02-22 Option Award | 2025-02-24 5:45 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 5,369 | $0 | 18,684 (Direct) | View |
2025-02-22 Disposition | 2025-02-24 5:43 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director | 5,369 | $0 | 22,570 (Direct) | View |
2025-02-22 Option Award | 2025-02-24 5:43 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director | 5,369 | $0 | 22,570 (Direct) | View |
2025-02-22 Disposition | 2025-02-24 5:41 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Sensenig Bethany Director | 5,369 | $0 | 5,369 (Direct) | View |
2025-02-22 Option Award | 2025-02-24 5:41 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Sensenig Bethany Director | 5,369 | $0 | 5,369 (Direct) | View |
2025-02-19 Option Award | 2025-02-21 4:57 pm | N/A 2035-02-19 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 24,500 | $0 | 32,951 (Direct) | View |
2025-02-19 Option Award | 2025-02-21 4:51 pm | N/A 2035-02-19 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director | 11,771 | $0 | 60,166 (Direct) | View |
2025-02-19 Option Award | 2025-02-21 4:50 pm | N/A 2035-02-19 | SUPERNUS PHARMACEUTICALS INC. | SUPN | NEWHALL CHARLES W III Director | 11,771 | $0 | 142,046 (Direct) | View |
2025-02-19 Option Award | 2025-02-21 4:49 pm | N/A 2035-02-19 | SUPERNUS PHARMACEUTICALS INC. | SUPN | GEMAYEL GEORGES Director | 11,771 | $0 | 25,086 (Direct) | View |
2025-02-19 Option Award | 2025-02-21 4:48 pm | N/A 2035-02-19 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Sensenig Bethany Director | 11,771 | $0 | 11,771 (Direct) | View |
2025-02-19 Option Award | 2025-02-21 4:47 pm | N/A 2035-02-19 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Barlow Carrolee Director | 11,771 | $0 | 28,972 (Direct) | View |
2025-02-19 Option Award | 2025-02-21 4:45 pm | N/A 2035-02-19 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 24,500 | $0 | 34,649 (Direct) | View |
2025-02-19 Option Award | 2025-02-21 4:44 pm | N/A 2035-02-19 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 24,500 | $0 | 31,405 (Direct) | View |
2025-02-19 Option Award | 2025-02-21 4:43 pm | N/A 2035-02-19 | SUPERNUS PHARMACEUTICALS INC. | SUPN | DEC TIMOTHY C Senior Vice-President & CFO | 44,500 | $0 | 52,591 (Direct) | View |
2025-02-20 Option Award | 2025-02-21 4:42 pm | N/A 2035-02-20 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 331,660 | $0 | 2,307,689 (Direct) | View |
2025-02-17 Option Award | 2025-02-19 4:54 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Khattar Jack A. President, CEO | 38,640 | $0 | 2,014,669 (Direct) | View |
2025-02-17 Option Award | 2025-02-19 4:35 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 2,625 | $0 | 11,076 (Direct) | View |
2025-02-05 Option Award | 2025-02-06 4:57 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 5,760 | $0 | 14,211 (Direct) | View |
2025-02-04 Exercise | 2025-02-05 4:37 pm | N/A 2031-02-19 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 9,477 | $0 | 14,399 (Direct) | View |
2025-02-04 Exercise | 2025-02-05 4:37 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 9,477 | $29.61 | 14,399 (Direct) | View |
2025-01-28 Exercise(A) | 2025-02-05 4:33 pm | N/A 2031-02-19 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 700 | $0 | 23,876 (Direct) | View |
2025-01-27 Exercise | 2025-01-29 5:04 pm | N/A 2031-02-19 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 3,273 | $0 | 31,453 (Direct) | View |
2025-01-28 Option Award | 2025-01-29 5:04 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 1,650 | $0 | 31,453 (Direct) | View |
2025-01-27 Exercise | 2025-01-29 5:04 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Bhatt Padmanabh P. Sr. VP of IP, CSO | 3,273 | $29.61 | 31,453 (Direct) | View |
2025-01-28 Option Award | 2025-01-29 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 1,875 | $0 | 8,780 (Direct) | View |
2025-01-28 Option Award | 2025-01-29 4:59 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Mottola Frank SVP, Quality, GMP, Ops, IT | 1,125 | $0 | 9,576 (Direct) | View |
2025-01-22 Exercise | 2025-01-23 4:33 pm | 2016-03-03 2025-03-03 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director | 20,000 | $0 | 48,395 (Direct) | View |
2025-01-22 Exercise | 2025-01-23 4:33 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Hudson Frederick M. Director | 20,000 | $9.13 | 48,395 (Direct) | View |